Insider trades
Forbion Growth Management B.V., 10% Owner of NewAmsterdam Pharma NAMS, has filed 14 purchases and 25 sales on the open market. The latest trade was on 24/12/30.
Forbion Growth Management B.V.
10% Owner
- Company
- NewAmsterdam Pharma NAMS
- First filing
- 23/11/02
- Trades
- 50 trades
- Buys / sales
- 14 / 25
- 12-month net buying
- No record
- Last trade
- 24/12/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 24/12/30 | 25/01/02 | 29,846 sh | $25.54 | $762,266.84 | −0.3% | |
NAMS | Open-market sale10b5-1 plan | 24/12/26–24/12/27 | 24/12/30 | 74,910 sh2 trades | $25.98avg. | $1,945,920.78 | −0.7% |
NAMS | Open-market sale10b5-1 plan | 24/12/20–24/12/24 | 24/12/26 | 91,068 sh4 trades | $25.58avg. | $2,329,439.48 | −0.8% |
NAMS | Open-market sale10b5-1 plan | 24/12/18–24/12/19 | 24/12/20 | 157,234 sh3 trades | $25.87avg. | $4,067,156.16 | −1.4% |
NAMS | Open-market sale10b5-1 plan | 24/12/16–24/12/17 | 24/12/18 | 115,480 sh3 trades | $25.95avg. | $2,996,206 | −1.0% |
NAMS | Open-market sale10b5-1 plan | 24/12/12–24/12/13 | 24/12/16 | 191,762 sh3 trades | $25.34avg. | $4,859,955.85 | −1.7% |
NAMS | Open-market sale10b5-1 plan | 24/12/10–24/12/11 | 24/12/12 | 462,288 sh5 trades | $25.40avg. | $11,740,604.46 | −3.9% |
NAMS | Open-market sale10b5-1 plan | 24/11/15–24/11/18 | 24/11/19 | 41,803 sh2 trades | $25.07avg. | $1,047,907.44 | −0.4% |
NAMS | Open-market sale10b5-1 plan | 24/11/13–24/11/14 | 24/11/15 | 10,898 sh2 trades | $25.01avg. | $272,548.32 | −0.1% |
| Open-market buy | 24/10/30 | 24/11/01 | 561,797 sh | $8.90 | $4,999,993.3 | +22.7% | |
ENGN | Open-market buy | 23/12/27–24/10/08 | 24/10/18 | 470,633 sh13 trades | $6.40avg. | $3,013,458.33 | +23.5% |
